Search

ISSN: 1735-403X eISSN: 2383-2886

April 2024, Vol 30, No. 2

Pharmaceutical Sciences is a peer-reviewed, and quarterly journal providing a forum for basic to clinical issues related to all areas of pharmaceutical sciences. It is the official journal of Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.
- Platinum Open Access (no processing or publication fees)
- Indexed in Web of Science Core Collection (Impact Factor 2022: 1.7) and Scopus
- Average time to first decision in 2023 (all decisions): 17 days
- Time to first post-review decision in 2023: 2-8 weeks
- Acceptance rate in 2023: 10%
- Publications from 18 countries (5 continents) in 2023

Original Research

1. Effect of zinc supplementation on serum mlondealdehyde and lipid profiles on beta thalassemia major patients

M Aboomardani*, M Rafraf, R Arefhosseini, M.R Rashidi

Pharm Sci. 2012;18(1): 25-32.

Article

PDF

XML

Cited By:

Short Communication

2. An In Vitro Aerosolization Efficiency Comparison of Generic and Branded Salbutamol Metered Dose Inhalers

Sara Rahimkhani, Saeed Ghanbarzadeh, Ali Nokhodchi, Hamed Hamishehkar*

Pharm Sci. 2017;23(1): 77-81. doi: 10.15171/PS.2017.12

Scopus ID: 85018527187

Article

PDF

XML

Cited By:

2

4

Research Article

3. Study of Combination of Nanoherbal Andaliman (Zanthoxylum acanthopodium) and Extra Virgin Olive Oil (EVOO) Effects in the Expression of Malondialdehyde (MDA), Heat Shock Protein-70 (HSP70) and Placental Histology of Preeclamptic Rats

Putri Cahaya Situmorang , Syafruddin Ilyas* , Salomo Hutahaean

Pharm Sci. 2019;25(3): 205-220. doi: 10.15171/PS.2019.37

Scopus ID: 85072799115

Article

PDF

XML

Cited By:

23

13

Research Article COVID-19

4. Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors

Mohammad Rizki Fadhil Pratama , Hadi Poerwono , Siswandono Siswodihardjo*

Pharm Sci. 2020;26(Suppl 1): S63-S77. doi: 10.34172/PS.2020.57

Scopus ID: 85097303712

Article

PDF

XML

Cited By:

4

2

Research Article COVID-19

5. Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease

Ahmed Ali Al-Karmalawy* , Radwan Alnajjar, Mohammed Dahab, Ahmed Metwaly, Ibrahim Eissa

Pharm Sci. 2021;27(Suppl 1): S109-S121. doi: 10.34172/PS.2021.3

Scopus ID: 85118951907

Article

PDF

XML

Cited By:

35

18

Research Article

6. Expression, Purification and Characterization of Anti-FGF7 Domain Antibody Identified Using Phage Display Technique

Ali Akbar Alizadeh , Mona Roshani , Omid Jamshidi Kandjani , Milad Soltani-Saif , Siavoush Dastmalchi*

Pharm Sci. 2022;28(3): 405-413. doi: 10.34172/PS.2021.64

Scopus ID: 85139857307

Article

PDF

XML

Cited By:

0

0

Research Article

7. In Vitro and In Silico Studies on the Anticancer and Antimicrobial Activity of Cu(II), Ni(II) and Co(II) Complexes with Bis (Pyrazolyl) Borate Derivative Ligand

Monireh Ghorbanpour , Behzad Soltani* , Ommoleila Molavi, Elnaz Mehdizadeh Aghdam

Pharm Sci. 2022;28(4): 564-571. doi: 10.34172/PS.2022.3

Scopus ID: 85136234803

Article

PDF

XML

Cited By:

5

2

Research Article

8. Fucoxanthin Inhibits the Proliferation of ABCC2-Over Expressing Cisplatin-Resistance Ovarian Cancer Cells via Inducing Apoptosis

Fatemeh Valinezhad Sani , Safa Kamalian, Hakimeh Abdi, Shiva Ghofrani, Arad Boustan, Fatemeh Mosaffa*

Pharm Sci. 2023;29(3): 320-327. doi: 10.34172/PS.2022.44

Scopus ID: 85164456817

Article

PDF

XML

Cited By:

0

0

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE

Powered by: